Placenta-Derived Mesenchymal Stem Cells (pMSCs) Reverse Diabetes-Associated Endothelial Complications in a...

Area of Science:

• Endocrinology
• Stem Cell Biology
• Vascular Biology

Background:

• Diabetes mellitus is a chronic inflammatory condition characterized by hyperglycemia and endothelial dysfunction.
• Hyperglycemia-induced oxidative stress damages endothelial cells, contributing to severe diabetic complications.
• Placenta-derived mesenchymal stem cells (pMSCs) possess anti-inflammatory and antioxidant properties with potential therapeutic applications.

Purpose of the Study:

• To investigate the therapeutic efficacy of pMSCs in mitigating diabetes-related endothelial injury and tissue damage.
• To evaluate the impact of pMSCs on metabolic homeostasis and glucose regulation in a diabetic mouse model.
• To assess the protective effects of pMSCs on kidney, heart, and eye tissues in vivo.

Main Methods:

• A streptozotocin (STZ)-induced diabetic mouse model was used to mimic type 1 diabetes.
• pMSCs were administered via intra-peritoneal injections.
• Metabolic tests (GTT, ITT) and histopathological analyses of kidney, heart, and eye tissues were performed.

Main Results:

• pMSCs did not restore metabolic homeostasis or improve glucose regulation in diabetic mice.
• Histopathological analysis revealed significant protective effects of pMSCs on kidney glomerular structure.
• pMSCs preserved cardiac blood vessels and retinal integrity, mitigating tissue damage.

Conclusions:

• pMSCs demonstrate significant potential in protecting against diabetic tissue injuries, particularly in the kidneys, heart, and eyes.
• While not improving glycemic control, pMSCs offer a promising therapeutic avenue for managing diabetic complications.
• Further research is warranted to optimize pMSC therapy for clinical application in diabetes management.